International trends in oesophageal cancer survival by histological subtype between 1995 and 2014

被引：55

作者：

Morgan, Eileen ^{[1
,2
]}

Soerjomataram, Isabelle ^{[1
]}

Gavin, Anna T. ^{[2
]}

Rutherford, Mark J. ^{[3
]}

Gatenby, Piers ^{[4
]}

Bardot, Aude ^{[1
]}

Ferlay, Jacques ^{[1
]}

Bucher, Oliver ^{[5
]}

De, Prithwish ^{[6
]}

Engholm, Gerda ^{[7
]}

Jackson, Christopher ^{[8
,9
]}

Kozie, Serena ^{[10
]}

Little, Alana ^{[11
]}

Moller, Bjorn ^{[12
]}

Shack, Lorraine ^{[13
]}

Tervonen, Hanna ^{[11
]}

Thursfield, Vicky ^{[14
]}

Vernon, Sally ^{[15
]}

Walsh, Paul M. ^{[16
]}

Woods, Ryan R. ^{[17
]}

Finley, Christian ^{[18
]}

Merrett, Neil ^{[19
]}

O'Connell, Dianne L. ^{[20
]}

Reynolds, John, V ^{[21
,22
]}

Bray, Freddie ^{[1
]}

Arnold, Melina ^{[1
]}

机构：

[1] Int Agcy Res Canc, Sect Canc Surveillance, Lyon, France

[2] Queens Univ Belfast, Northern Ireland Canc Registry, Belfast, Antrim, North Ireland

[3] Univ Leicester, Dept Hlth Sci, Biostat Res Grp, Leicester, Leics, England

[4] Univ Surrey, Dept Clin & Expt Med, Guildford, Surrey, England

[5] Canc Care Manitoba, Dept Epidemiol & Canc Registry, Winnipeg, MB, Canada

[6] Ontario Hlth Canc Care Ontario, Surveillance & Canc Registry, Toronto, ON, Canada

[7] Danish Canc Soc Res Ctr, Canc Surveillance & Pharmacoepidemiol, Copenhagen, Denmark

[8] Canc Soc New Zealand, Wellington, New Zealand

[9] Univ Otago Sch Med, Dept Med, Dunedin, New Zealand

[10] Saskatchewan Canc Agcy, Regina, SK, Canada

[11] Canc Inst NSW, Canc Informat & Anal, Alexandria, NSW, Australia

[12] Canc Registry Norway, Dept Registrat, Oslo, Norway

[13] Alberta Hlth Serv, Canc Control Alberta, Edmonton, AB, Canada

[14] Canc Council Victoria, Victorian Canc Registry, Melbourne, Vic, Australia

[15] Publ Hlth England, Natl Canc Registrat & Anal Serv, Cambridge, England

[16] Natl Canc Registry Ireland, Cork, Ireland

[17] BC Canc Agcy, Vancouver, BC, Canada

[18] McMaster Univ, Dept Surg, Hamilton, ON, Canada

[19] Western Sydney Univ, Sch Med, Sydney, NSW, Australia

[20] Canc Council NSW, Canc Res Div, Sydney, NSW, Australia

[21] St James Hosp, Natl Ctr Oesophageal Canc, Dublin, Ireland

[22] Trinity Coll Dublin, Dublin, Ireland

来源：

GUT | 2021年 / 70卷 / 02期

关键词：

CHEMOTHERAPY; CHEMORADIOTHERAPY; ADENOCARCINOMA; POPULATION; SURGERY; CLASSIFICATION; GUIDELINES;

D O I：

10.1136/gutjnl-2020-321089

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Introduction Survival from oesophageal cancer remains poor, even across high-income countries. Ongoing changes in the epidemiology of the disease highlight the need for survival assessments by its two main histological subtypes, adenocarcinoma (AC) and squamous cell carcinoma (SCC). Methods The ICBP SURVMARK-2 project, a platform for international comparisons of cancer survival, collected cases of oesophageal cancer diagnosed 1995 to 2014, followed until 31st December 2015, from cancer registries covering seven participating countries with similar access to healthcare (Australia, Canada, Denmark, Ireland, New Zealand, Norway and the UK). 1-year and 3-year age-standardised net survival alongside incidence rates were calculated by country, subtype, sex, age group and period of diagnosis. Results 111 894 cases of AC and 73 408 cases of SCC were included in the analysis. Marked improvements in survival were observed over the 20-year period in each country, particularly for AC, younger age groups and 1 year after diagnosis. Survival was consistently higher for both subtypes in Australia and Ireland followed by Norway, Denmark, New Zealand, the UK and Canada. During 2010 to 2014, survival was higher for AC compared with SCC, with 1-year survival ranging from 46.9% (Canada) to 54.4% (Ireland) for AC and 39.6% (Denmark) to 53.1% (Australia) for SCC. Conclusion Marked improvements in both oesophageal AC and SCC survival suggest advances in treatment. Less marked improvements 3 years after diagnosis, among older age groups and patients with SCC, highlight the need for further advances in early detection and treatment of oesophageal cancer alongside primary prevention to reduce the overall burden from the disease.

引用

页码：234 / 242

页数：9

共 47 条

[1] Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial [J].

Al-Batran, Salah-Eddin ;

Homann, Nils ;

Pauligk, Claudia ;

Goetze, Thorsten O. ;

Meiler, Johannes ;

Kasper, Stefan ;

Kopp, Hans-Georg ;

Mayer, Frank ;

Haag, Georg Martin ;

Luley, Kim ;

Lindig, Udo ;

Schmiegel, Wolff ;

Pohl, Michael ;

Stoehlmacher, Jan ;

Folprecht, Gunnar ;

Probst, Stephan ;

Prasnikar, Nicole ;

Fischbach, Wolfgang ;

Mahlberg, Rolf ;

Trojan, Joerg ;

Koenigsmann, Michael ;

Martens, Uwe M. ;

Thuss-Patience, Peter ;

Egger, Matthias ;

Block, Andreas ;

Heinemann, Volker ;

Illerhaus, Gerald ;

Moehler, Markus ;

Schenk, Michael ;

Kullmann, Frank ;

Behringer, Dirk M. ;

Heike, Michael ;

Pink, Daniel ;

Teschendorf, Christian ;

Loehr, Carmen ;

Bernhard, Helga ;

Schuch, Gunter ;

Rethwisch, Volker ;

von Weikersthal, Ludwig Fischer ;

Hartmann, Joerg T. ;

Kneba, Michael ;

Daum, Severin ;

Schulmann, Karsten ;

Weniger, Joerg ;

Belle, Sebastian ;

Gaiser, Timo ;

Oduncu, Fuat S. ;

Guentner, Martina ;

Hozaeel, Wael ;

Reichart, Alexander .

LANCET, 2019, 393 (10184) :1948-1957

[2] Guidelines for the management of oesophageal and gastric cancer [J].

Allum, William H. ;

Blazeby, Jane M. ;

Griffin, S. Michael ;

Cunningham, David ;

Jankowski, Janusz A. ;

Wong, Rachel .

GUT, 2011, 60 (11) :1449-1472

[3] Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study [J].

Arnold, Melina ;

Rutherford, Mark J. ;

Bardot, Aude ;

Ferlay, Jacques ;

Andersson, Therese M-L ;

Myklebust, Tor Age ;

Tervonen, Hanna ;

Thursfield, Vicky ;

Ransom, David ;

Shack, Lorraine ;

Woods, Ryan R. ;

Turner, Donna ;

Leonfellner, Suzanne ;

Ryan, Susan ;

Saint-Jacques, Nathalie ;

De, Prithwish ;

McClure, Carol ;

Ramanakumar, Agnihotram V. ;

Stuart-Panko, Heather ;

Engholm, Gerda ;

Walsh, Paul M. ;

Jackson, Christopher ;

Vernon, Sally ;

Morgan, Eileen ;

Gavin, Anna ;

Morrison, David S. ;

Huws, Dyfed W. ;

Porter, Geoff ;

Butler, John ;

Bryant, Heather ;

Currow, David C. ;

Hiom, Sara ;

Parkin, D. Max ;

Sasieni, Peter ;

Lambert, Paul C. ;

Moller, Bjorn ;

Soerjomataram, Isabelle ;

Bray, Freddie .

LANCET ONCOLOGY, 2019, 20 (11) :1493-1505

[4] Global incidence of oesophageal cancer by histological subtype in 2012 [J].

Arnold, Melina ;

Soerjomataram, Isabelle ;

Ferlay, Jacques ;

Forman, David .

GUT, 2015, 64 (03) :381-387

[5]

Bancewicz J, 2002, LANCET, V359, P1727

[6]

Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]

[7]

Brenner H, 1996, CANCER-AM CANCER SOC, V78, P2004, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.3.CO

[8]

2-6

[9] The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis [J].

Codipilly, Don Chamil ;

Chandar, Apoorva Krishna ;

Singh, Siddharth ;

Wani, Sachin ;

Shaheen, Nicholas J. ;

Inadomi, John M. ;

Chak, Amitabh ;

Iyer, Prasad G. .

GASTROENTEROLOGY, 2018, 154 (08) :2068-+

[10] Standard cancer patient population for age standardising survival ratios [J].

Corazziari, I ;

Quinn, M ;

Capocaccia, R .

EUROPEAN JOURNAL OF CANCER, 2004, 40 (15) :2307-2316

← 1 2 3 4 5 →